Bringing this blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner to support them earlier in their journeys.

This test is intended as an aid in the diagnosis of SARS‑CoV‑2 infection in individuals with or without symptoms consistent with COVID‑19. This product is intended for professional use in …

The CoaguChek® XS provides quantitative prothrombin time testing for the monitoring of warfarin therapy, giving fast and reliable results anywhere at any time.

The cobas ® HIV-1/HIV-2 Qualitative Test for use on the cobas® 5800/ 6800/8800 Systems is the first automated nucleic acid test to enable differentiation between HIV-1 and HIV-2 infections, …

The test is intended to be used as an aid in the identification of CRC patients who should not be treated with Erbitux® (cetuximab) or with Vectibix® (panitumumab) when KRAS Codon 12 or …

cobas® HIV-1 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 systems IVD Contact us

Jun 10, 2024 · The test expands Roche’s extensive molecular point-of-care testing portfolio, offering greater flexibility to meet testing needs amid evolving regional prevalence of …

This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older with symptoms of COVID-19 within the …

This method sheet is for use with the Coaguchek XS system, which is intended for use by professional healthcare providers for quantitative prothrombin time testing for monitoring …

Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high …